echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: A risk score for detecting subclinical rheumatoid arthritis-associated interstitial lung disease

    A&R: A risk score for detecting subclinical rheumatoid arthritis-associated interstitial lung disease

    • Last Update: 2022-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    OBJECTIVE: The course of subclinical rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is heterogeneous; some patients may experience disease progression leading to pulmonary symptoms and decreased respiratory functi.


    OBJECTIVE: The course of subclinical rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is heterogeneous; some patients may experience disease progression leading to pulmonary symptoms and decreased respiratory functi.


    Methods: One discovery sample and one validation sample were obtained from patients without pulmonary symptoms in 2 prospective RA cohorts ( ESPOIR and TRANSLATE2 ) who underwent chest HRCT scan.


    RESULTS: The discovery and replication populations included 163 and 89 patients , respective.


    Conclusions: This study identifies and validates a risk score for RA-ILD with or without MUC5B rs35705950 MUC5B rs35705950 that identifies patients at high risk for subclinical RA-ILD requiring screening with chest HRCT scan.


    Source: Juge,.


    Juge,.
    .
    , Granger,.
    , et .
    (2022), A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disea.
    Arthritis Rheumat.
    Accepted Author Manuscri.
    https://d.
    org/11002 /a.
    42162 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.